Overview

Oxycodone and Sufentanil for Analgesia in Hip Surgery

Status:
Enrolling by invitation
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
We design this randomized controlled trial to compare the safety and efficacy of Oxycodone and Sufentanil for postoperative patient-controlled analgesia in patients undergoing hip surgery, with a view to finding the optimal postoperative analgesic regime with fewer adverse reactions and promoting patients' rehabilitation.
Phase:
Phase 4
Details
Lead Sponsor:
West China Hospital
Treatments:
Analgesics
Dsuvia
Oxycodone
Sufentanil